GSK Investigational Site
Observatory, Cape Town 7925
0 studies enrolling now · 6 studies all time
What they study most
HIV Infections, Infection, Human Immunodeficiency Virus, Social Phobia
Studies at this site
- Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients — Running, not enrolling
- A Dose-Range Finding Clinical Trial Study in Human Immunodeficiency Virus (HIV-1) Infected Treatment-Naive Adults — Stopped early
- Regimen Switch to Dolutegravir/Lamivudine Fixed Dose Combination From Current Antiretroviral Regimen in HIV-1 Infected and Virologically Suppressed Adults (SALSA) — Completed
- An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1) — Completed
- HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections — Completed
- Treatment Of Patients With Social Anxiety Disorder — Completed